ProMIS Neurosciences, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

WARRANTS

WARRANTS

9 Months Ended

Sep. 30, 2026

7.	WARRANTS

As of September 30, 2026, outstanding Common Share warrants and exercise prices related to unit offerings are as follows:


Exercise		Number of
Price $		Warrants	Expiry date
US$50.50		314,170	January 2027
US$187.50		13,831	April 2028
US$152.50		2,767	April 2028
US$43.75		449,084	February 2029
US$62.50		314,170	July 2029
US$31.25		1,129,324	July 2030
US$14.40		6,915,296	February 2031
US$0.25		74,673	None
US$0.0001		100,000	None
		9,313,315

There were no warrant exercises in the three or nine months ended September 30, 2026. There were 26,816 and 340,986 warrants that expired in the three and nine months ended September 30, 2026, respectively.